China Medical Reports Q3 Adjusted EPS of $0.43

China Medical Technologies Inc CMED reports its Q3 adjusted EPS at $0.43, versus the consensus of $0.43. CMED reports its Q3 revenue at $33.9 million, versus the consensus of $33.3 million. CMED shares gained 1.89% to $13.50 in after-hours trading. Read more from Benzinga's Company news.